Clinical Trial Update: A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing tiotropium inhalation once daily versus salmeterol inhalation twice daily in COPD, evaluating arterial blood gases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Serevent (salmeterol)
• Spiriva (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED